Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lillicrap

Showing results (161-170 of 216) with videos related to

Pageof 22
Sort By:
Blood|August 11, 2010
Functional characterization of a 13-bp deletion (c.-1522_-1510del13) in the promoter of the von Willebrand factor gene in type 1 von Willebrand diseaseMaha Othman, Yvette Chirinian, Christine Brown, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
The mechanistic and structural role of von Willebrand factor in endotoxemia-enhanced deep vein thrombosis in miceSeon Jae Choi, Courtney N Dwyer, Lindsy Rapkin, et al.
Cellular Immunology|January 18, 2016
Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A miceSriram Krishnamoorthy, Tongyao Liu, Douglas Drager, et al.
Haematologica|March 13, 2025
Regulation of immune responses to therapeutic factor VIII by transplacental delivery of Fc-fused immunodominant factor VIII domains or peptidesAlejandra Reyes-Ruiz, Sandrine Delignat, Aurélien Azam, et al.
Nature Reviews. Disease Primers|July 25, 2024
von Willebrand diseaseOmid Seidizadeh, Jeroen C J Eikenboom, Cécile V Denis, et al.
Biomaterials|September 25, 2010
Hierarchical scaffold design for mesenchymal stem cell-based gene therapy of hemophilia BDaniel L Coutu, Jessica Cuerquis, Rouwayda El Ayoubi, et al.
Thrombosis and Haemostasis|February 9, 2011
Frequency of platelet type versus type 2B von Willebrand disease. An international registry-based studyAlexander Hamilton, Margareth Ozelo, Jayne Leggo, et al.
Blood|July 28, 2019
Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patientsLaura L Swystun, Kenichi Ogiwara, Orla Rawley, et al.
Blood|October 31, 2002
Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectorsMarinee K L Chuah, Gudrun Schiedner, Lieven Thorrez, et al.
Journal of Thrombosis and Haemostasis : JTH|April 25, 2022
von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient-derived endothelial colony-forming cellsMackenzie Bowman, Lara Casey, Soundarya N Selvam, et al.
Pageof 22

Showing results (161-170 of 216) with videos related to

Sort By:
Pageof 22
Blood|August 11, 2010
Functional characterization of a 13-bp deletion (c.-1522_-1510del13) in the promoter of the von Willebrand factor gene in type 1 von Willebrand diseaseMaha Othman, Yvette Chirinian, Christine Brown, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
The mechanistic and structural role of von Willebrand factor in endotoxemia-enhanced deep vein thrombosis in miceSeon Jae Choi, Courtney N Dwyer, Lindsy Rapkin, et al.
Cellular Immunology|January 18, 2016
Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A miceSriram Krishnamoorthy, Tongyao Liu, Douglas Drager, et al.
Haematologica|March 13, 2025
Regulation of immune responses to therapeutic factor VIII by transplacental delivery of Fc-fused immunodominant factor VIII domains or peptidesAlejandra Reyes-Ruiz, Sandrine Delignat, Aurélien Azam, et al.
Nature Reviews. Disease Primers|July 25, 2024
von Willebrand diseaseOmid Seidizadeh, Jeroen C J Eikenboom, Cécile V Denis, et al.
Biomaterials|September 25, 2010
Hierarchical scaffold design for mesenchymal stem cell-based gene therapy of hemophilia BDaniel L Coutu, Jessica Cuerquis, Rouwayda El Ayoubi, et al.
Thrombosis and Haemostasis|February 9, 2011
Frequency of platelet type versus type 2B von Willebrand disease. An international registry-based studyAlexander Hamilton, Margareth Ozelo, Jayne Leggo, et al.
Blood|July 28, 2019
Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patientsLaura L Swystun, Kenichi Ogiwara, Orla Rawley, et al.
Blood|October 31, 2002
Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectorsMarinee K L Chuah, Gudrun Schiedner, Lieven Thorrez, et al.
Journal of Thrombosis and Haemostasis : JTH|April 25, 2022
von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient-derived endothelial colony-forming cellsMackenzie Bowman, Lara Casey, Soundarya N Selvam, et al.
Pageof 22